Wei Yu Chen, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 71 Prospect Ave, Anesthesiologist Care, P.c., Hudson, NY 12534 Phone: 518-828-8307 Fax: 518-828-8528 |
Dr. Andrew Z Qian, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 71 Prospect Ave, Anesthesiology, Hudson, NY 12534 Phone: 518-828-8307 Fax: 518-828-8528 |
Jalin Sama, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 71 Prospect Ave, Anesthesiologist Care, P.c., Hudson, NY 12534 Phone: 518-828-8307 Fax: 518-828-8528 |
Mark D Weibman, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 71 Prospect Ave, Hudson, NY 12534 Phone: 914-672-2966 |
Dr. John F Mathews, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 71 Prospect Ave, Hudson, NY 12534 Phone: 518-828-8307 Fax: 518-828-8528 |
Steven J Maxwell, D.O. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 71 Prospect Ave, Anesthesiologist Care, P.c., Hudson, NY 12534 Phone: 518-828-8307 Fax: 518-828-8528 |
Dr. Tomasz Andrejuk, M.D. Anesthesiology - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 71 Prospect Ave, Suite L30, Hudson, NY 12534 Phone: 518-697-3061 Fax: 518-697-3059 |
News Archive
Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc., has been awarded funding of up to $400,000 by The Michael J. Fox Foundation for ongoing clinical research of the Company's investigational carbidopa-levodopa extended release (CD-LD ER) product IPX066, which is intended to treat the motor symptoms of Parkinson's disease (PD).
Researchers from the Broad Institute and MIT have teamed up with colleagues from the University of Tokyo to form the first high definition picture of the Cas9 complex - a key part of the CRISPR-Cas system used by scientists as a genome-editing tool to silence genes and probe the biology of cells. Their findings, which are reported this week in Cell, are expected to help researchers refine and further engineer the tool to accelerate genomic research and bring the technology closer to use in the treatment of human genetic disease.
It's an ordinary workday, and the lunch hour at Commerce Court is bustling with people. Wait a minute! What the heck is going on? Where did those hockey sticks come from? How did those nets appear? There's a road hockey game in progress!! But what the heck is with those guys wearing jockstraps over their suits? After an extraordinary inaugural event that raised $2.4 million for cancer research at The Princess Margaret Cancer Centre and Canadian Cancer Society, Road Hockey To Conquer Cancer will kick off its sophomore campaign with a spontaneous road hockey game on Tuesday, February 7, 2012 at 12:30pm in the courtyard at Commerce Court.
MP Biomedicals LLC announced today that it has received approval of its investigational new drug application (IND) with the U.S. Food and Drug Administration (FDA) to start pivotal clinical trials in the USA with the MP Diagnostics™ HTLV-I/II ELISA 4.0 and HTLV Blot.2.4. Studies will be conducted within the American Red Cross, the California Department of Public Health, and LABS, Inc. The company is working closely with the principal investigator of the American Red Cross sites, Dr. Susan Stramer, Executive Scientific Officer.
A new adjustable female shoe based on a new memory shape composite of leather and Nitinol material, is now available. The new material allows fitting the shoe to the foot shape, after obtaining anthropometric measurements through the Shopintantshoe portable scanner and modifying it with the "Shoptool", a machine that completes the process directly in the shop.
› Verified 5 days ago